Nature Reviews Urology

Article	Citations
Novel intravesical gemcitabine delivery system (TAR-200) for neoadjuvant treatment of MIBC: context is everything	214
Texture analysis for patient selection	195
Single-cell and spatial sequencing of kidney cancer	143
Human-relevant urothelial model provides insight into infection strategies and host response	128
Krause corpuscles act as genital vibration detectors	99
Semen quality recovery following COVID-19	97
PARP inhibitors plus enzalutamide to treat mCRPC	81
Urine microbiota differ in bladder cancer	78
Preclinical models of bladder cancer: BBN and beyond	76
Micro-ultrasound for prostate cancer	75
High-dose chemotherapy for relapsed testicular germ cell tumours	72
Time for women-centred gynaecology	71
Advancing the state of the art in congenital obstructive uropathy	69
Considering urology in a planetary context	65
FOXA2–KIT-driven lineage plasticity in NEPC	64
Proteomic-based analysis of testicular interstitial fluid	64
A clinical guide to rare male sexual disorders	64
Prevalence of gender dysphoria in Japan	59
A new text message-based platform for self-management of patients with IC/BPS	56
Promise without practice — charting the path forward for bladder cancer biomarkers	53
Overcoming antibiotic resistance in complicated UTI	53
Madrid plays host to a celebration of urology	51
Metaverse in surgery — origins and future potential	51
What happens in Vegas … shapes the future of urology	50
Microfluidic sperm selection	50

Hallmark discoveries in the biology of non-Wilms tumour childhood kidney cancers	49
The evolving landscape of monogenic nephrolithiasis and therapeutic innovations	49
Evolution of the World Health Organization semen analysis manual: where are we?	48
Leveraging generative AI to enhance doctor–patient communication	48
Pembrolizumab + axitinib beyond first-line therapy for mRCC	46
Prognostic and therapeutic potential of senescent stromal fibroblasts in prostate cancer	46
Antibiotic therapy for treating overactive bladder is not supported by clinical evidence	46
A non-invasive assay for UTUC diagnosis	45
COVID can’t kill CopMich collaboration	44
Vaccination to prevent untreatable gonorrhoea	42
The mechanism of action of neuromodulation in the treatment of overactive bladder	42
Measuring and improving the cradle-to-grave environmental performance of urological procedures	42
Quest for a genetic biomarker for sickle cell disease priapism: rationale, progress and implications	39
Resolving the puzzle of same-sex sexual interactions	39
PEACEing together prostate cancer therapy	38
Efficacy of the Revi system in treating urgency urinary incontinence	38
Personalized 3D models for prostate cancer surgery	37
Bioinformatics in urology — molecular characterization of pathophysiology and response to treatment	36
EMUC25: shaping tomorrow’s uro-oncology care	36
Pain management in percutaneous nephrolithotomy — an approach rooted in pathophysiology	36
Quality checkpoints in the MRI-directed prostate cancer diagnostic pathway	34
Persistent Müllerian duct syndrome — a rare but important cause of male factor infertility	33
Sexual orientation, gender identity and COVID: a complicated picture	33
Effect of high glucose on E. coli	32
Rucaparib improves PFS in patients with BRCA1/2-altered mCRPC	31
The magic of MagSToNE	30
Cribriform morphology affects mpMRI imaging	29
Secondary kidney stones — remove or leave?	29
A distinct TAM subset mediates immunotherapy resistance in prostate cancer	28
Women in urology: the past	28
AUA returns to its former glory in Chicago	27
Promising efficacy of UTI vaccines as an alternative to antibiotics	27
Prostate cancer in transgender women — challenges in research and clinical care	26
Robots learning to imitate surgeons — challenges and possibilities	25
Microultrasonography-guided prostate cancer biopsy	25
Excluding PLND in favourable intermediate-risk prostate cancer: a PSMA-PET-directed perspective	24
Successful mentorship for women in urology — a new era	24
Racial disparities in prostate cancer in the UK and the USA: similarities, differences and steps forwards	24
Author Correction: Can PROMs improve racial equity in outcomes after prostatectomy?	23
Centralization of care for rare genetic syndromes associated with cancer: improving outcomes and advancing research on VHL disease	23
Technical modifications to improve erectile function recovery after radical prostatectomy	23
Is it time to rethink the current patient-reported outcome measures?	22
A clinical overview of people living with HIV and genitourinary cancer care	22
Videourodynamics — role, benefits and optimal practice	22
Current and emerging strategies to curb antibiotic-resistant urinary tract infections	22
Sexual health and treatment-related sexual dysfunction in sexual and gender minorities with prostate cancer	22
Detecting lymph node metastases for personalized radiotherapy in patients with prostate cancer	21
Going in circles: circMGA–HNRNPL feedback loop in bladder cancer	21
Management and cost of stent encrustation in pregnancy	21
Overall survival with adjuvant pembrolizumab in renal cell carcinoma — the shock of the lightning	19

Fathers matter too: sperm-borne epigenetic messages link paternal exposures to next-generation health	19
Evolving language reflects evolving understanding: updated terms for anatomical description in i/VSC/DSD	19
AI for antibiotic design	18
Pride, not prejudice	18
Beyond maternal exercise: paternal exercise adaptations mediated by sperm microRNA signatures	18
The future of patient-derived xenografts in prostate cancer research	16
Androgen receptor pathway inhibitor combination in prostate cancer	16
Turning up the heat: CTLA4 blockade in urothelial cancer	16
De-clear cell differentiated renal cell carcinoma — a new therapeutic target	16
The value of women urologists — individual and institutional imperatives to address salary equity	15
Uncovering a link between COVID-19 and renal cell carcinoma	15
Immune-based therapies in penile cancer	15
The prognostic role of stroma in UTUC	15
Turning back time in the testes	15
The evolving treatment landscape of metastatic urothelial cancer	15
New evidence and novel techniques for assessing intraoperative margins during radical prostatectomy	14
Breaking the silence: normalizing receptive anal intercourse for patients, for people and for myself	14
The shifting treatment paradigm of metastatic renal cell carcinoma	13
Current and future pharmacotherapy for female sexual dysfunction	13
We all get erections — de-gendering sexual arousal dysfunction in the ICD	13
Och AI the noo from SIU	13
Urinary tract infections in children	13
Neoadjuvant lutetium PSMA, the TIME and immune response in high-risk localized prostate cancer	12
Improved phenotypic classification of male infertility to promote discovery of genetic causes	12
Pelvic-fascia-sparing techniques and outcomes with RARP	12
Hallmark discoveries in the biology of Wilms tumour	12
CMA mediates resistance to androgen inhibitors in prostate cancer	11
Vitamins as regulators of calcium-containing kidney stones — new perspectives on the role of the gut microbiome	11
Power up to investigate PrEP	11
The unclear role of PET–CT in localized radiorecurrent prostate cancer	11
Effects of COVID-19 vaccine on semen parameters	11
Men hold the balance of power	11
Metabolism, mitochondria and metastasis in kidney cancer	10
ARNEO: neoadjuvant degarelix + apalutamide before surgery for high-risk prostate cancer	10
Author Correction: Atypical intraductal proliferation in prostate biopsy — a diagnostic grey zone with clinical implications	10
A prompt-based stewardship to reduce extended-spectrum antibiotic treatment in UTI	10
BAUSing back in Birmingham	10
Diagnosis of ccRCC	10
Male infertility and somatic health — insights into lipid damage as a mechanistic link	10
Mechanisms of the intestinal and urinary microbiome in kidney stone disease	10
Tuft cells in prostate cancer	10
Mellow yellow: BilR reduces bilirubin to urobilinogen	10
Spatiotemporal trends in human semen quality	10
Semen parameters across testicular cancer stages	9
Chlorination by-products in drinking water — association with bladder cancer risk	9
Syphilis on the rise — a need for alternative therapies and vaccines	9
MRI diagnosis and radical prostatectomy outcomes	9
Testosterone replacement therapy and spermatogenesis in reproductive age men	9
Advances in sliding clip renorrhaphy for partial nephrectomy	9
Pronouns in English: a user’s guide	9
Sperm activity affected by endometriosis	9
Stepping up to prevent bacterial vaginosis recurrence	9
Pathophysiology and potential multimodal therapeutic strategies for IC/BPS	8
Visual clues — dermatological manifestations of sexually transmitted infections in men	8
Particulate matter leaves a bitter taste in testes	8
A great gathering at the 4th Clinical and Scientific Advances in UTI conference	8
Urology on a changing planet: links between climate change and urological disease	8
The ins and outs of penile erection	8
Smooth muscle cell plasticity in pelvic organ prolapse	8
Artificial intelligence in the management of prostate cancer	8
Influence of substance use on male reproductive health and offspring outcomes	7
Feasibility and potential of an MRI-based prostate cancer screening	7
ADT intensification to treat biochemically recurrent prostate cancer	7
Genetic and biological drivers of prostate cancer disparities in Black men	7
EAU26: innovation, patient care and a touch of mythology	7
Mutagenic effect of chemotherapy on sperm DNA and implications for family planning	7
Prescribing clinician specialty influences adherence to PrEP	7
Von Hippel–Lindau protein signalling in clear cell renal cell carcinoma	7
Clinical trial design for non-muscle-invasive bladder cancer	7
The future of pelvic lymph node dissection for urological malignancies	7
The effects of diet on prostate cancer outcomes	7
Neurogenic lower urinary tract dysfunction in ageing men with spinal cord injury	6
The prostatic middle lobe: clinical significance, presentation and management	6
Gut microbiome’s effect on immunotherapy response	6
Prognostic and predictive biomarkers for immunotherapy in advanced renal cell carcinoma	6
Being a non-native English speaker in science and medicine	6
Exploring the impact of lipid stress on sperm cytoskeleton: insights and prospects	6
New insights into APOBEC-mediated mutagenesis in prostate cancer	6
Revisiting the dual role of androgens and oestrogens in mammalian sex differentiation with a focus on genitalia	6
Pregnancy and parental leave in medicine and academia — a focus on urology	6

Improving care for transgender and non-binary individuals	6
An app for optimizing UTI screening	6
Reply to ‘Management of very young fetuses with LUTO’	5
Should we screen for sleep apnoea in men with idiopathic infertility?	5
A urologist as a urological patient	5
Managing autonomic dysreflexia during urological care in individuals living with spinal cord injury	5
Sexual transfer of bacteria for forensic use	5
GDF15 blockade can reduce immunotherapy resistance in urothelial cancer	5
Prostate cancer epigenetics — from pathophysiology to clinical application	4
The testosterone paradox of advanced prostate cancer: mechanistic insights and clinical implications	4
PIONEER big data platform for prostate cancer: lessons for advancing future real-world evidence research	4
Advancing perioperative care in MIBC: insights from NIAGARA	4
Optimizing cystoscopy and TURBT: enhanced imaging and artificial intelligence	4
Non-human primates as a translational model for the study of male reproductive health	4
A vagina on a chip to model microbiome–host interactions	4
Landmarks in the evolution of prostate biopsy	4
Patient-reported outcomes in metastatic renal cell carcinoma trials using combinations versus sunitinib as first-line treatment	4
CRISPR–Cas9 potential for identifying novel therapeutic targets in muscle-invasive bladder cancer	4
Iatrogenic upper urinary tract injuries during ureteroscopy for urolithiasis: a comprehensive review on incidence, mechanisms and preventative strategies	4
The effect of red blood cell disorders on male fertility and reproductive health	4
SRD5A2 and emerging therapies in androgen-driven disorders	4
Metastasis development in non-muscle-invasive bladder cancer	4
Human sperm RNA in male infertility	3
Exercise, diet and psychological support for patients with testicular cancer	3
Knockout of extended pelvic lymph node dissection during radical cystectomy	3
Emerging evidence for sequencing and combining PSMA-based therapies in prostate cancer	3
Promoting the health of men of all backgrounds: educating ourselves to build trust and improve care	3
A new surgical procedure to treat BPH	3
Immunoliposome targeting IL-30	3
Control of oncogenic signalling in ccRCC	3
Evolving the surgical approach for bladder cancer — robotic versus open radical cystectomy	3
Understanding and integrating cytoreductive nephrectomy with immune checkpoint inhibitors in the management of metastatic RCC	3
Perspectives on chemsex	3
Can systematic biopsy be omitted from the prostate cancer diagnostic pathway?	3
Metabolic alterations drive enzalutamide resistance	3
Mapping the human prostate at the cellular level	3
The potential role of the microbiota in prostate cancer pathogenesis and treatment	3
Health-related quality of life after curative treatment for muscle-invasive bladder cancer	3
From foes to friends: rethinking the role of lymph nodes in prostate cancer	3
The opportunities and barriers for developing tumour-infiltrating lymphocyte therapy for patients with advanced genitourinary cancers	3
Generative AI in scientific publishing: disruptive or destructive?	3
Proteomic characterization of bladder cancer	3
Clinical hypnosis improves LUTS	3
Author Correction: Advances in sliding clip renorrhaphy for partial nephrectomy	3
Accessing information in the AI age	3
Utility of PSA screening in transgender women receiving oestrogens	3
PSMA-targeted fluorescence guidance for robotic-assisted prostatectomy	2
Better PrEParation for HIV prevention in minority groups	2
The dynamic roles of the bladder tumour microenvironment	2
AI for drug discovery	2
WGC in patients with localized prostate cancer	2
Focusing on male infertility	2
Robotic kidney transplantation	2
20 years of ‘spilling the tea’ in urology	2
Microplastics in the penis	2
UPEC-mediated alteration of host mitochondrial function — a survival strategy	2
Patient-reported toxic effects of hypofractionated versus conventional RT	2
Artificial intelligence in academic writing: a paradigm-shifting technological advance	2
A multi-modal approach for decision making in bladder cancer	2
Adjuvant personalized cancer vaccine: is this the end of metastatic kidney cancer	2
The International Penile Prosthesis Implant Consensus Forum: clinical recommendations and surgical principles on the inflatable 3-piece penile prosthesis implant	2
Molecular and therapeutic landscape of non-clear cell renal carcinoma	2
Key lessons from AI in other endoscopic disciplines to guide the future in cystoscopy	2
Effects of the environment on the evolution of the vertebrate urinary tract	2
Targeting TGCT	2
Body fluid-derived stem cells — an untapped stem cell source in genitourinary regeneration	2
Metabolic flexibility in ccRCC	2
PROTACs for prostate cancer	2
EAU à la mode	2
The burden of kidney transplant evaluation — an older adults’ perspective	2
Experimental in vitro, ex vivo and in vivo models in prostate cancer research	2
Supplementary selenium and vitamin E in non-muscle-invasive bladder cancer	2
Intravesical ICIs to reduce toxicity in NMIBC	2
Abortion is a urology workforce issue	2
Digital twins for personalized treatment in uro-oncology in the era of artificial intelligence	2
Temporary cessation versus continued TKI therapy for RCC	1
AI in prostate MRI: enhancing accuracy and reducing overdiagnosis	1
Modelling AR mutations	1
Urine biomarkers in bladder cancer — current status and future perspectives	1
Biomarkers of disease recurrence in stage I testicular germ cell tumours	1
Melon seed extract protects against testis metal toxicity	1
20 years of taxane therapy in prostate cancer — the past, present and future	1
Author Correction: Metaverse in surgery — origins and future potential	1
Interactions between androgen and IGF1 axes in prostate tumorigenesis	1
Immunoproteasome inhibition in CRPC	1
Road for inclusion and caring in urology starts at AUA 22	1
PSMA-PET to detect prostate cancer recurrence after radiotherapy	1
Intralesional heterogeneity on PSMA PET–CT predicts mCRPC outcomes	1
Urology’s carbon footprint	1
Treatment de-escalation for stage II seminoma	1
First-morning urine samples to study the urobiome	1
ML-guided decision for patient discharge location	1
A new signalling-based system for germ cell reprogramming	1
Understanding and managing the cardiovascular risks of androgen deprivation therapy for prostate cancer	1
Molecular characterization of tRCC	1